Kew O M, Sutter R W, Nottay B K, McDonough M J, Prevots D R, Quick L, Pallansch M A
Division of Viral and Rickettsial Diseases, National Center for Infectious Diseases, National Immunization Program, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA.
J Clin Microbiol. 1998 Oct;36(10):2893-9. doi: 10.1128/JCM.36.10.2893-2899.1998.
VP1 sequences were determined for poliovirus type 1 isolates obtained over a 189-day period from a poliomyelitis patient with common variable immunodeficiency syndrome (a defect in antibody formation). The isolate from the first sample, taken 11 days after onset of paralysis, contained two poliovirus populations, differing from the Sabin 1 vaccine strain by approximately 10%, differing from diverse type 1 wild polioviruses by 19 to 24%, and differing from each other by 5.5% of nucleotides. Specimens taken after day 11 appeared to contain only one major poliovirus population. Evolution of VP1 sequences at synonymous third-codon positions occurred at an overall rate of approximately 3.4% per year over the 189-day period. Assuming this rate to be constant throughout the period of infection, the infection was calculated to have started approximately 9.3 years earlier. This estimate is about the time (6. 9 years earlier) the patient received his last oral poliovirus vaccine dose, approximately 2 years before the diagnosis of immunodeficiency. These findings may have important implications for the strategy to eliminate poliovirus immunization after global polio eradication.
对一名患有常见可变免疫缺陷综合征(抗体形成缺陷)的脊髓灰质炎患者在189天内分离出的1型脊髓灰质炎病毒毒株进行了VP1序列测定。在瘫痪发作11天后采集的首个样本中的分离株含有两种脊髓灰质炎病毒群体,与Sabin 1疫苗株的差异约为10%,与多种1型野生脊髓灰质炎病毒的差异为19%至24%,彼此之间的核苷酸差异为5.5%。在第11天之后采集的样本似乎仅含有一种主要的脊髓灰质炎病毒群体。在189天的时间里,同义第三密码子位置的VP1序列进化总体速率约为每年3.4%。假设在整个感染期间该速率保持恒定,经计算感染大约在9.3年前开始。这一估计时间与患者最后一次口服脊髓灰质炎病毒疫苗的时间(早6.9年)相近,大约在免疫缺陷诊断前2年。这些发现可能对全球根除脊髓灰质炎后消除脊髓灰质炎病毒免疫的策略具有重要意义。